Johan Lindbäck

7.7k total citations · 3 hit papers
105 papers, 5.3k citations indexed

About

Johan Lindbäck is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Johan Lindbäck has authored 105 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Cardiology and Cardiovascular Medicine, 16 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Johan Lindbäck's work include Atrial Fibrillation Management and Outcomes (31 papers), Acute Myocardial Infarction Research (19 papers) and Heart Failure Treatment and Management (18 papers). Johan Lindbäck is often cited by papers focused on Atrial Fibrillation Management and Outcomes (31 papers), Acute Myocardial Infarction Research (19 papers) and Heart Failure Treatment and Management (18 papers). Johan Lindbäck collaborates with scholars based in Sweden, United States and Canada. Johan Lindbäck's co-authors include Lars Wallentin, Ulf Stenestrand, Stefan James, Bo Lagerqvist, Tage Nilsson, Jonas Oldgren, Ziad Hijazi, Christopher B. Granger, Renato D. Lópes and Agneta Siegbahn and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Johan Lindbäck

102 papers receiving 5.0k citations

Hit Papers

Long-Term Outcomes with Drug-Eluting Stents versus Bare-M... 2007 2026 2013 2019 2007 2016 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Lindbäck Sweden 40 3.3k 1.7k 840 680 540 105 5.3k
Christoph Naber Germany 30 2.5k 0.7× 2.0k 1.1× 1.4k 1.6× 1.0k 1.5× 976 1.8× 143 4.1k
Stefan H. Jacobson Sweden 42 962 0.3× 1.3k 0.8× 393 0.5× 934 1.4× 1.2k 2.1× 214 7.1k
Francesco Manguso Italy 52 3.9k 1.2× 1.8k 1.1× 223 0.3× 561 0.8× 1.6k 3.1× 144 9.4k
Alex Koyfman United States 35 728 0.2× 1.2k 0.7× 301 0.4× 693 1.0× 801 1.5× 245 4.9k
Elliott Bennett‐Guerrero United States 40 1.7k 0.5× 2.5k 1.4× 98 0.1× 846 1.2× 570 1.1× 144 6.2k
Juan F. Delgado Spain 41 2.5k 0.8× 2.2k 1.3× 123 0.1× 935 1.4× 958 1.8× 329 5.6k
Edward Hulten United States 32 1.7k 0.5× 1.3k 0.7× 2.0k 2.4× 937 1.4× 350 0.6× 88 4.0k
Amit Gupta India 43 494 0.1× 2.9k 1.7× 409 0.5× 1.8k 2.6× 473 0.9× 333 5.9k
Ntobeko Ntusi South Africa 32 2.5k 0.8× 658 0.4× 1.2k 1.5× 344 0.5× 577 1.1× 187 4.3k
Sreekanth Vemulapalli United States 45 6.2k 1.9× 2.2k 1.3× 879 1.0× 2.0k 3.0× 4.1k 7.7× 219 7.5k

Countries citing papers authored by Johan Lindbäck

Since Specialization
Citations

This map shows the geographic impact of Johan Lindbäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Lindbäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Lindbäck more than expected).

Fields of papers citing papers by Johan Lindbäck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Lindbäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Lindbäck. The network helps show where Johan Lindbäck may publish in the future.

Co-authorship network of co-authors of Johan Lindbäck

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Lindbäck. A scholar is included among the top collaborators of Johan Lindbäck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Lindbäck. Johan Lindbäck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eggers, Kai M., Gorav Batra, Bertil Lindahl, et al.. (2024). Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clinical Chemistry and Laboratory Medicine (CCLM). 62(6). 1167–1176. 3 indexed citations
2.
Lindbäck, Johan, Vítor Tedim Cruz, Martin Ingelsson, et al.. (2024). Validation of a web-based self-administered test for cognitive assessment in a Swedish geriatric setting. PLoS ONE. 19(2). e0297575–e0297575. 1 indexed citations
3.
Lindbäck, Johan, John H. Alexander, Christopher B. Granger, et al.. (2024). Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Journal of the American Heart Association. 13(7). e033720–e033720. 5 indexed citations
4.
Lindbäck, Johan, Alexander P. Benz, John W. Eikelboom, et al.. (2024). Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation. Circulation. 150(14). 1090–1100. 5 indexed citations
5.
Lindbäck, Johan, Alexander P. Benz, John W. Eikelboom, et al.. (2024). Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation. Journal of the American Heart Association. 14(2). e038860–e038860. 1 indexed citations
6.
Benz, Alexander P., Ziad Hijazi, Johan Lindbäck, et al.. (2023). Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation. EP Europace. 25(7). 6 indexed citations
7.
Hijazi, Ziad, Johan Lindbäck, Jonas Oldgren, et al.. (2023). Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC‐AF risk scores. American Heart Journal. 261. 55–63. 7 indexed citations
8.
Hijazi, Ziad, Alexander P. Benz, Johan Lindbäck, et al.. (2022). Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation. European Heart Journal. 44(3). 208–218. 29 indexed citations
9.
Hjort, Marcus, Kai M. Eggers, Tatevik Ghukasyan Lakic, et al.. (2022). Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial. Journal of the American Heart Association. 12(1). e027466–e027466. 18 indexed citations
10.
Pol, Tymon, Ziad Hijazi, Johan Lindbäck, et al.. (2021). Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation. Cardiovascular Research. 118(9). 2112–2123. 20 indexed citations
11.
Pol, Tymon, Ziad Hijazi, Johan Lindbäck, et al.. (2021). Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. Open Heart. 8(1). e001471–e001471. 7 indexed citations
12.
Held, Claes, Nermin Hadziosmanovic, Johan Lindbäck, et al.. (2021). Risk markers of incident atrial fibrillation in patients with coronary heart disease. American Heart Journal. 233. 92–101. 6 indexed citations
13.
Benz, Alexander P., Ziad Hijazi, Johan Lindbäck, et al.. (2021). Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation. Circulation. 143(19). 1863–1873. 29 indexed citations
14.
Hijazi, Ziad, Lars Wallentin, Johan Lindbäck, et al.. (2020). Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation. Journal of the American Heart Association. 9(24). e018984–e018984. 41 indexed citations
15.
Hijazi, Ziad, Christopher B. Granger, Stefan H. Hohnloser, et al.. (2020). Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation. Journal of the American Heart Association. 9(18). e017155–e017155. 5 indexed citations
16.
Sylvén, Sara, et al.. (2017). Risk factors for exclusive breastfeeding lasting less than two months—Identifying women in need of targeted breastfeeding support. PLoS ONE. 12(6). e0179402–e0179402. 45 indexed citations
17.
Hijazi, Ziad, Johan Lindbäck, Agneta Siegbahn, et al.. (2014). A new biomarker based risk score for predicting major bleeding in atrial fibrillation - the ABC (age, biomarkers, current disease) risk score. European Heart Journal. 35. 357–357. 2 indexed citations
18.
Hållmarker, Ulf, Karl Michaëlsson, Johan Ärnlöv, et al.. (2014). OUTCOME AFTER MYOCARDIAL INFARCTION IN A COHORT STUDY OF CROSS COUNTRY SKIERS IN SWEDEN. Journal of the American College of Cardiology. 63(12). A1345–A1345. 10 indexed citations
19.
Jernberg, Tomas, et al.. (2010). Effect of Angiotensin-Converting Enzyme Inhibition on One-Year Mortality and Frequency of Repeat Acute Myocardial Infarction in Patients With Acute Myocardial Infarction. The American Journal of Cardiology. 105(9). 1229–1234. 37 indexed citations
20.
Kragsterman, Björn, Håkan Pärsson, Johan Lindbäck, David Bergqvist, & Martin Björck. (2006). Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: Results from a population-based registry. Journal of Vascular Surgery. 44(1). 79–85. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026